Canada markets closed

Celon Pharma S.A. (8RP.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
3.36000.0000 (0.00%)
At close: 08:24AM CEST
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
164,394
164,394
161,915
169,559
135,480
Cost of Revenue
66,819
66,819
66,462
61,715
36,643
Gross Profit
97,575
97,575
95,453
107,844
98,837
Operating Expenses
Selling General and Administrative
-
-
-
37,384
44,129
Total Operating Expenses
128,574
128,574
133,455
121,451
105,575
Operating Income or Loss
-30,999
-30,999
-38,002
-13,607
-6,738
Interest Expense
2,662
2,662
1,671
1,553
667
Income Before Tax
-19,968
-19,968
-36,446
-15,087
-5,588
Income Tax Expense
8,156
8,156
2,831
-3,480
-4,671
Income from Continuing Operations
-28,124
-28,124
-39,277
-11,607
-917
Net Income
-28,124
-28,124
-39,277
-11,607
-917
Net Income available to common shareholders
-28,124
-28,124
-39,277
-11,607
-917
Basic EPS
-0.50
-0.55
-0.77
-0.25
-0.02
Diluted EPS
-0.50
-0.55
-0.77
-0.25
-0.02
Basic Average Shares
50,696
51,057
51,024
46,677
45,000
Diluted Average Shares
50,707
51,057
51,035
46,684
45,000